ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Contraceptives, Oral, Combined

Also written as “Combined oral contraceptive [ethinyl estradiol/ norethisterone (EE/NET)]”, “Combined oral contraceptives (COC)” and “COC”.

Its studies are mostly in Bipolar Disorder, led by 3 companies.

Drug pageContraceptives, Oral, Combined: every studyAll 17 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 1, since Jun 6, 20073 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
GlaxoSmithKline10 open or runningphase 1since Jun 6, 2007Jun 6, 2007none ahead
Merck KGaA, Darmstadt, Germanyits history only10 open or runningphase 1since Oct 8, 2025Oct 8, 2025none ahead
Viatrisits history only10 open or runningphase 1since Jan 29, 2020Jan 29, 2020none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of GlaxoSmithKline only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jun 6, 2007First study: phase 1 study in Bipolar DisorderFirst studyNCT00483535 · 12 enrolled · United Kingdom

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

The one study GlaxoSmithKline leads. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT00483535Bipolar Disorder · United Kingdom1TerminatedNov 16, 200712

How it is read

Names in the registry

  • “Combined oral contraceptive [ethinyl estradiol/ norethisterone (EE/NET)]”, 1 entry
  • “Combined oral contraceptives (COC)”, 1 entry
  • “COC”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.